900174-90-5 Usage
Uses
Used in Pharmaceutical Industry:
(R)-2-(2-(isopropylsulfonyl)phenyl)pyrrolidine is used as an intermediate in the synthesis of various organic compounds for the development of drugs targeting different therapeutic areas. Its unique chemical structure and chirality make it a valuable building block for creating novel pharmaceutical agents.
Used in Research and Development:
(R)-2-(2-(isopropylsulfonyl)phenyl)pyrrolidine is employed as a research chemical to study its potential biological activities and pharmacological effects. This helps in understanding its role in drug discovery and development, as well as in exploring its potential applications in various therapeutic areas.
Used in Drug Synthesis:
(R)-2-(2-(isopropylsulfonyl)phenyl)pyrrolidine is used as a key component in the synthesis of new drugs, particularly in the pharmaceutical industry. Its unique properties and reactivity contribute to the development of innovative and effective therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 900174-90-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,0,1,7 and 4 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 900174-90:
(8*9)+(7*0)+(6*0)+(5*1)+(4*7)+(3*4)+(2*9)+(1*0)=135
135 % 10 = 5
So 900174-90-5 is a valid CAS Registry Number.
900174-90-5Relevant academic research and scientific papers
PHENYLGLYCINAMIDE DERIVATIVES USEFUL AS ANTICOAGULANTS
-
Page/Page column 138, (2008/06/13)
The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.
